Global In-Vitro Fertilization Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, and Reagents & AccessoriesBy Type;
Conventional IVF and IVF with ICSIBy Procedure;
Fresh Donor and Frozen DonorBy Providers;
Fertility Clinics, and Hospitals & Others SettingBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)In-Vitro Fertilization Market Overview
In-Vitro Fertilization Market (USD Million)
In-Vitro Fertilization Market was valued at USD 7,143.49 million in the year 2024. The size of this market is expected to increase to USD 12,809.07 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.7%.
Global In-Vitro Fertilization Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 8.7 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 8.7 % |
Market Size (2024) | USD 7,143.49 Million |
Market Size (2031) | USD 12,809.07 Million |
Market Concentration | Medium |
Report Pages | 308 |
Major Players
- Cooper Companies Inc.
- Cook Group
- Vitrolife
- Thermo Fisher Scientific, Inc.
- Esco Micro Pte. Ltd.
- Genea Limited
- IVFtech ApS
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global In-Vitro Fertilization Market
Fragmented - Highly competitive market without dominant players
The in vitro fertilization (IVF) market is growing rapidly due to the rising prevalence of infertility and the increasing demand for advanced reproductive solutions. Around 15% of couples worldwide face infertility challenges, boosting the adoption of IVF as an effective treatment option. IVF success rates have improved with technological advancements, and over 45% of treatments are now sought by individuals over 35, driven by later-life childbearing trends.
Rising Awareness and Demand for Fertility Treatments
Growing awareness of fertility solutions has accelerated IVF adoption, especially as more patients look for personalized treatment plans. With technological breakthroughs like genetic screening and embryo freezing, success rates have increased by 40-45%, further fueling market demand.
Fertility Tourism Driving Market Growth
Fertility tourism is on the rise as patients seek more affordable IVF options abroad, representing an expected 25% of the market. This growing trend contributes to market expansion and diversifies IVF access worldwide.
Regulatory and Ethical Advancements Supporting Market Growth
Government regulations and insurance coverage for IVF treatments are making fertility care more accessible, with 20-30% of patients utilizing insurance to ease costs. These policy changes are expected to broaden IVF treatment accessibility, enhancing the market’s overall growth.
In-Vitro Fertilization Market Recent Developments
-
In January 2022, Ferring Pharmaceuticals announced the acquisition of Merck’s global in vitro fertilization (IVF) business. This strategic move is expected to strengthen Ferring’s position in the IVF market by enhancing its portfolio of fertility treatments and technologies. By acquiring Merck’s IVF assets, Ferring aims to expand its capabilities in offering comprehensive reproductive healthcare solutions. This acquisition marks a significant step in Ferring’s ongoing commitment to advancing fertility care and supporting couples worldwide in their journey to parenthood.
-
In February 2022, AbbVie and SpringWorks Therapeutics formed a strategic collaboration aimed at developing innovative IVF treatments for infertility. This partnership combines AbbVie’s expertise in pharmaceutical development with SpringWorks’ capabilities in clinical research, focusing on enhancing fertility treatment options. The collaboration is expected to accelerate the development of advanced solutions to address infertility, further expanding both companies’ contributions to the growing IVF market.
In-Vitro Fertilization Market Segment Analysis
In this report, the In-Vitro Fertilization Market has been segmented by Product, Type,Procedure, Providers, and Geography.
In-Vitro Fertilization Market, Segmentation by Product
The In-Vitro Fertilization Market has been segmented by Product into Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, and Reagents & Accessories.
Micromanipulators
Micromanipulators are crucial tools in the in-vitro fertilization (IVF) market, accounting for a significant share of approximately 25%. These precision instruments are essential for manipulating eggs and sperm during the IVF process, ensuring accurate fertilization. The demand for micromanipulators is expected to increase with the growing number of IVF procedures and the continuous advancements in reproductive technologies.
Incubators
Incubators are vital for the growth and development of embryos during the IVF process. This segment represents around 20% of the market. With technological innovations in incubator systems, such as time-lapse monitoring, the IVF success rate has improved significantly. As more fertility clinics adopt these advanced incubators, the segment is expected to experience steady growth, driven by the increasing demand for high-quality fertility treatments.
Cabinets
Cabinets play a significant role in maintaining the ideal storage conditions for eggs, embryos, and sperm in IVF labs. This segment accounts for approximately 15% of the IVF market. As the need for sterile and controlled environments rises, the demand for high-performance cabinets designed for IVF applications is growing. Cabinets that provide precise temperature and humidity control are essential for ensuring the success of IVF procedures.
Imaging System
Imaging systems, including ultrasound and advanced 3D imaging technologies, hold a substantial share of the IVF market, accounting for around 18%. These systems are crucial for monitoring embryo development and assessing the quality of eggs and sperm during IVF. With advancements in imaging technologies, such as enhanced resolution and real-time monitoring, the market is witnessing an increase in demand for these systems to improve IVF outcomes.
Laser System
Laser systems in the IVF market represent approximately 12% of the overall market share. These systems are widely used for procedures such as embryo hatching and sperm DNA fragmentation. The demand for laser systems is expected to rise as advancements in laser technologies continue to improve IVF success rates, leading to better outcomes for patients undergoing assisted reproductive treatments.
Reagents & Accessories
Reagents and accessories are fundamental to the IVF process and account for around 10% of the IVF market. These products, including culture media, reagents, and petri dishes, are essential for supporting embryo growth and fertilization. As IVF procedures become more sophisticated, the demand for high-quality reagents and accessories is growing to ensure optimal results for patients undergoing treatment.
In-Vitro Fertilization Market, Segmentation by Type
The In-Vitro Fertilization Market has been segmented by Type into Conventional IVF, and IVF with ICSI.
Conventional IVF
Conventional IVF is a traditional fertilization technique in which sperm and eggs are combined in a petri dish, allowing natural fertilization to occur. It is widely used in cases where there are no severe male infertility issues and contributes to around 40% of IVF treatments. Its cost-effectiveness and non-invasive nature make it a preferred first-line treatment for many patients.
IVF with ICSI
IVF with ICSI (Intracytoplasmic Sperm Injection) has become the leading choice in modern fertility treatments, accounting for about 60% of all IVF procedures. This method involves directly injecting a single sperm into the egg, significantly increasing the chances of fertilization, especially in cases of male infertility. Its high success rate and applicability in complex cases drive its widespread adoption.
In-Vitro Fertilization Market, Segmentation by Procedure
In this report, the In-Vitro Fertilization Market has been segmented by Procedure into Fresh Donor, Frozen Donor, Fresh Non-Donor, and Frozen Non-Donor.
Fresh Donor
Fresh donor IVF procedures, making up about 15% of the market, involve the use of freshly harvested eggs from a donor for immediate fertilization and embryo transfer. This method is known for slightly better success rates due to the freshness of the eggs, although it requires close timing between donor and recipient cycles.
Frozen Donor
Accounting for around 25% of IVF treatments, frozen donor procedures offer enhanced flexibility and scheduling. By using previously frozen donor eggs, clinics can reduce the coordination burden and improve patient convenience. Advances in cryopreservation have significantly boosted the effectiveness of this method
In-Vitro Fertilization Market, Segmentation by Providers
In this report, the In-Vitro Fertilization Market has been segmented by Providers into Fertility Clinics, and Hospitals & Others Setting
Fertility Clinics
Fertility clinics represent the largest share of IVF services globally, capturing nearly 65% of the market. These centers are equipped with specialized technology and expert teams that focus exclusively on reproductive care, enabling higher success rates and customized treatment approaches. Their patient-centric services make them the primary choice for many undergoing IVF.
Hospitals & Others Setting
Hospitals and other care settings hold approximately 35% of the IVF provider market. They offer integrated medical care and are well-suited for patients with complex health conditions. These institutions combine IVF services with broader healthcare infrastructure, offering comprehensive support for those with coexisting medical needs.
In-Vitro Fertilization Market, Segmentation by Geography
In this report, the In-Vitro Fertilization Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Regions and Countries Analyzed in this Report
In-Vitro Fertilization Market Share (%), by Geographical Region
North America
North America dominates the IVF landscape, contributing around 35% to the global market. The region benefits from cutting-edge fertility technologies, comprehensive insurance coverage, and a growing number of fertility centers offering advanced reproductive services.
Europe
Holding close to 30% of the IVF market, Europe boasts a mature healthcare system and supportive fertility policies. Increased maternal age and access to public and private fertility services are major growth factors across the region.
Asia Pacific
With an approximate 20% market share, Asia Pacific stands out as the fastest-growing IVF market. Factors such as rising healthcare expenditure, growing fertility awareness, and the emergence of international IVF centers are boosting regional growth.
Middle East and Africa
Middle East and Africa account for nearly 8% of the IVF market. The rise in infertility rates, coupled with increasing openness toward fertility treatments, is enhancing demand for assisted reproduction across this region.
Latin America
Latin America captures about 7% of the IVF market. Improvements in healthcare access, increasing urbanization, and expanding fertility awareness are fostering gradual growth in IVF adoption across the region.
In-Vitro Fertilization Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of In-Vitro Fertilization Market. These factors include; Market Drivers, Restraints and Opportunities.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Rising infertility rates among global population
- Delayed parenthood trends in urban societies
- Technological advancements in IVF procedures
-
Growing medical tourism for fertility treatment - The rise of medical tourism for fertility treatments is becoming a major driving force in the growth of the in-vitro fertilization (IVF) market. As infertility rates continue to rise, an increasing number of individuals and couples are seeking effective fertility solutions, with many choosing to travel abroad for treatments. Medical tourism offers a cost-effective alternative for those who find the high prices of IVF procedures in their home countries unaffordable. Patients are increasingly turning to countries where IVF treatments are more budget-friendly without compromising the quality of care.
Countries like India, Thailand, and Spain have emerged as top destinations for IVF treatment, attracting patients due to their state-of-the-art medical facilities and highly skilled fertility specialists. These regions have become well-known for their advanced IVF technologies, high success rates, and competitive pricing, making them attractive options for individuals seeking affordable yet reliable fertility treatments. The availability of cutting-edge healthcare and expert care at a fraction of the cost found in many developed countries has significantly contributed to the growth of medical tourism in this sector.
In addition to cost savings, shorter waiting times are another factor fueling the rise in medical tourism for IVF. In several developed nations, long waiting periods for fertility treatments can cause frustration and anxiety for patients eager to begin their family-building journey. Medical tourism provides a solution by offering quicker access to treatment, helping patients avoid long delays and receive the necessary care at a more efficient pace. This prompt access to IVF procedures is particularly appealing to those looking for timely fertility solutions.
As awareness of affordable, high-quality fertility treatments abroad continues to grow, more patients are opting for medical tourism as a practical solution to their fertility challenges. This trend is expected to keep driving the IVF market, as people seek a combination of cost-effectiveness, faster access to care, and top-tier fertility treatment. The increasing demand for IVF treatments through medical tourism is set to continue shaping the future of the IVF market globally, offering patients better options for starting their families.
Restraints:
- High cost of IVF treatment cycles
- Ethical concerns and regulatory limitations
- Limited success rates in older patients
-
Lack of awareness in rural regions - Rural areas remains a significant challenge for the growth of the in-vitro fertilization (IVF) market. In many rural communities, infertility is still a delicate and often stigmatized issue, surrounded by cultural misconceptions and traditional beliefs. As a result, many individuals and couples are not aware of the fertility treatments available to them, including IVF, which limits their ability to make informed decisions about their reproductive health. This gap in knowledge significantly hinders the access to fertility solutions in these regions, preventing people from seeking help when needed.
Rural populations often face geographical barriers to accessing specialized medical facilities that offer advanced reproductive treatments. IVF requires specialized equipment, skilled professionals, and well-equipped clinics, which are typically concentrated in urban centers. For individuals living in remote areas, the distance to these specialized centers makes it challenging to consider IVF as a practical option. As a result, many in rural areas do not pursue treatment, either due to lack of awareness or the inconvenience of traveling long distances to receive care.
Financial constraints also play a role in limiting access to IVF in rural regions. Many people in these areas are unaware of the financial support options available for fertility treatments, such as insurance coverage or financing plans. Without knowledge of how to afford such treatments, the cost becomes an insurmountable barrier. This combination of financial limitations and informational gaps means that IVF remains out of reach for many in rural communities, further hindering the growth of the market in these regions.
To overcome these challenges, it is essential to implement educational campaigns and awareness programs to inform rural populations about available fertility treatments. Expanding access to fertility clinics and services in underserved areas, coupled with increased knowledge about IVF, could significantly boost demand. By bridging the information gap, the IVF market could see a more widespread adoption of fertility treatments, ensuring that people in all regions have access to the reproductive care they need.
Opportunities:
- Emerging markets increasing IVF adoption
- Innovations in embryo freezing techniques
- Government support for fertility treatments
-
Expanding fertility clinics in developing countries - Presents a valuable opportunity for the in-vitro fertilization (IVF) market. As infertility awareness increases and healthcare infrastructure improves in these regions, there is a growing demand for advanced fertility treatments. However, many developing countries still face barriers to accessing IVF, with limited availability of specialized clinics. By expanding fertility centers in these areas, healthcare providers can meet the rising demand for IVF and ensure more individuals and couples have access to affordable and effective fertility care.
In many developing countries, the lack of awareness about fertility treatments is a significant obstacle. The expansion of IVF clinics in these regions would play a key role in educating the population about the available options, making IVF a more accessible solution for those struggling with infertility. Additionally, it would reduce the reliance on medical tourism, allowing patients to receive treatment locally without the added costs and logistical challenges of traveling abroad for fertility care. This local availability can help make IVF a viable option for many who may have otherwise considered it out of reach.
Expanding fertility clinics in developing countries has the potential to drive economic growth. These clinics not only serve the local population but can also attract international patients seeking affordable, high-quality fertility care. As IVF centers grow, they can stimulate the local economy by creating jobs and encouraging the development of related industries, such as pharmaceuticals, medical supplies, and laboratory services. This can strengthen the overall healthcare infrastructure in these regions, benefiting both local communities and the healthcare industry.
Investing in the expansion of fertility clinics in developing countries is crucial for improving global access to IVF. With increased availability of these services, more people will be able to receive the fertility treatments they need, helping to address the growing demand for reproductive healthcare worldwide. As these clinics continue to grow and evolve, they will play a vital role in transforming the IVF landscape and offering greater opportunities for family-building to individuals and couples across the globe.
In-Vitro Fertilization Market Competitive Landscape Analysis
Key players in In-Vitro Fertilization Market include:
- CooperSurgical Inc.
- Vitrolife
- Cook Medical Inc.
- Hamilton Thorne Ltd.
- Thermo Fisher Scientific
- Fujifilm Irvine Scientific
- Nikon Corporation
- Esco Micro Pte. Ltd.
- Olympus
- Kitazato Corporation
- Corning Incorporated
- Carl Zeiss AG
- Fertipro NV
- Eppendorf
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Type
- Market Snapshot, By Procedure
- Market Snapshot, By Providers
- Market Snapshot, By Region
- In-Vitro Fertilization Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising infertility rates among global population
- Delayed parenthood trends in urban societies
- Technological advancements in IVF procedures
- Growing medical tourism for fertility treatment
- Restraints
- High cost of IVF treatment cycles
- Ethical concerns and regulatory limitations
- Limited success rates in older patients
- Lack of awareness in rural regions
- Opportunities
- Emerging markets increasing IVF adoption
- Innovations in embryo freezing techniques
- Government support for fertility treatments
- Expanding fertility clinics in developing countries
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- In-Vitro Fertilization Market, By Product, 2021 - 2031 (USD Million)
-
Micromanipulators
-
Incubators
-
Cabinets
-
Imaging System
-
Laser System
-
Reagents & Accessories
-
- In-Vitro Fertilization Market, By Type, 2021 - 2031 (USD Million)
-
Conventional IVF
-
IVF with ICSI
-
-
In-Vitro Fertilization Market, By Procedure, 2021 - 2031 (USD Million)\
-
Fresh Donor
-
Frozen Donor
-
-
In-Vitro Fertilization Market, By Providers, 2021 - 2031 (USD Million)
-
Fertility Clinics
-
Hospitals & Others Setting
-
- In-Vitro Fertilization Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- In-Vitro Fertilization Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- CooperSurgical Inc.
- Vitrolife
- Cook Medical Inc.
- Hamilton Thorne Ltd.
- Thermo Fisher Scientific
- Fujifilm Irvine Scientific
- Nikon Corporation
- Esco Micro Pte. Ltd.
- Olympus
- Kitazato Corporation
- Corning Incorporated
- Carl Zeiss AG
- Fertipro NV
- Eppendorf
- Company Profiles
- Analyst Views
- Future Outlook of the Market